Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Allergies - Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
MiCardia Corporation - MiCardia Corporation Receives US FDA Market Clearance for Dynaplasty Annuloplasty Devices
QPS - QPS' Bio-Kinetic Clinical Applications Phase I Unit Announces Collaboration with Quintiles
Vyteris - Dutton Associates Announces Investment Opinion: Vyteris Rating Speculative Buy In Update By Dutton Associates
Bone Research - New bone research study findings recently were published by M.A. Karsdal and co-researchers
Cancer Vaccines - Research on cancer vaccines discussed by R.J. Amato and co-researchers
Colon Cancer - Studies conducted at H.Y. Sheikh et al on colon cancer recently published
Gastric Cancer - Researchers' work from University of Ulsan focuses on gastric cancer
Immunization - Researchers at University of Louvain publish new data on immunization
Kaposi Sarcoma - New Kaposi sarcoma data have been reported by researchers at National Cancer Institute
Leukemia - New leukemia research from University of Texas outlined
Melanoma - Research from University of Michigan in the area of melanoma published
Non-Small Cell Lung Cancer - Data from University of Strasbourg provide new insights into non-small cell lung cancer
Non-Small Cell Lung Cancer - Study findings from O. Arrieta et al broaden understanding of non-small cell lung cancer
Prostatic Hyperplasia - Studies from University of Florence yield new data on prostatic hyperplasia
Pseudomyxoma Peritonei - New research on pseudomyxoma peritonei from A.L. Farquharson and co-authors summarized
Small Cell Lung Cancer - New small cell lung cancer data have been reported by M. Sorensen and co-authors
Solid Cancer - Research from University of London provides new data on solid cancer
T-Cell Lymphoma - Research from University of Groningen yields new findings on t-cell lymphoma
Thrombocytopenic Purpura - Research results from B. Godeau and co-authors update knowledge of thrombocytopenic purpura
Acute Myeloid Leukemia Therapy - New findings from University of Pennsylvania, Abramson Cancer Center in the area of acute myeloid leukemia therapy published
Blindness - Safety study indicates gene therapy for blindness improves vision
Bristol-Myers Squibb Company - Study Published in New England Journal of Medicine Shows ERBITUX Improved Survival in First-Line Recurrent And/Or Metastatic Head and Neck Cancer
Cell Genesys, Inc. - Cell Genesys Reconfirms Ongoing Plans with FDA for Phase 3 Program for GVAX Immunotherapy for Prostate Cancer While on Partial Clinical Hold
Circassia Ltd - Circassia Achieves Successful Phase II Clinical Results With Toleromune Anti-Allergy Technology
Clinical Trial Research - Cerimon Pharmaceuticals Announces Positive Results from a Phase II Clinical Study of Its Diclofenac Sodium Patch for Acute Pain
Columbia Laboratories, Inc. - Columbia Laboratories to Release Top Line Results of Phase II Lidocaine Study in Late September
Hepatitis C Virus - Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
Herpes Zoster Virus - Epiphany Biosciences to Continue Phase 2 Shingles Study After Interim Analysis; Plans Follow-On Clinical Trial Studying Post-Herpetic Neuralgia (PHN)
ImVisioN Therapeutics AG - ImVisioN Therapeutics Starts Phase I Clinical Trial of IVN201 Against Cat Dander Allergy and Raises CHF 4.6 M
Inspire Pharmaceuticals, Inc. - Inspire Announces Plans for Clinical Testing of New Compound INS117548 for the Treatment of Glaucoma
Lung Cancer - New Approach Uses a Common Virus to Combat Deadly Lung Cancer
Lux Biosciences, Inc. - Lux Biosciences' Investigational Therapy for Uveitis, Luveniq, to be Featured at 7th International Symposium on Uveitis
Menopause - Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
Obecure Ltd. - Obecure Recruits First Patient in Phase II Obesity Study in Pre-Menopause Women
Oxygen Biotherapeutics, Inc. - Oxygen Biotherapeutics, Inc. Sets FDA Meeting Date for Proposed Phase IIb Oxycyte Clinical Trial
Pharmacokinetics - ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications
Rexahn Pharmaceuticals, Inc. - Rexahn Pharmaceuticals Names KCSA Strategic Communications as Investor Relations Counsel
Rexahn Pharmaceuticals, Inc. - Rexahn Pharmaceuticals Receives FDA Approval to Initiate Phase II Trial for Serdaxin in Patients with Major Depressive Disorders
Surgery - Omeros Announces Patient Enrollment in Phase 1/Phase 2 Study of OMS302
Type 2 Diabetes - Novo Nordisk New Data From a Phase 3 Study Confirms Clinical Benefits of Once-Daily Liraglutide in the Management of Type 2 Diabetes
Type 2 Diabetes - Transition Therapeutics Dose First Patient in Phase 2 Clinical Study of TT-223 in Type 2 Diabetes
Xel Pharmaceuticals, Inc. - Xel Pharmaceuticals Announces Successful Completion of Prototype Once-A-Week Huperzine a Transdermal Patch for Alzheimer's Disease
XenoPort, Inc. - XenoPort to Expand Clinical Development of XP19986
Zosano Pharma, Inc. - Zosano Pharma, Inc. Announces Positive Results of Phase 2 Trial With PTH Transdermal Patch in Osteoporosis
